Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...

Aza–ven combination outperforms standard care in AML patients eligible for intensive chemotherapy

In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen ...
Calgary HeraldOpinion

Leong: Despite Calgary Transit budget boost, long way to go for better bus service

Unless someone is lucky enough to have a direct bus stop at both ends of their trip, they’ll need time for walking to and ...

East Tennessee Democrats hope to build on special election momentum

Michaela Barnett, the Democratic challenger to Knoxville's U.S. Rep. Tim Burchett, thinks she can make inroads in 2nd ...
News-Medical.Net on MSN

Aza-ven shows superior outcomes compared to induction chemotherapy in AML patients

In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen ...
The Malaysian Reserve

Lilly’s Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)

In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a ...
CNN

republican party

Not all candidates are listed. Candidates are ranked in order of votes or state delegates received during primaries and caucuses and not by the most recent estimated number of pledged delegates. The ...